FDA Approved: ROFLUMILAST — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approves Micro Labs Limited's generic roflumilast (original ANDA) for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

ORIG AP for ROFLUMILAST (ROFLUMILAST)